Background and aims: To assess the levels of total testosterone in the metabolic syndrome patients.
Material and Methods: We included ninety-six patients in our study, forty-nine with metabolic syndrome according to the definition of International Diabetes Federation (IDF) and forty-seven as control. Anthropometric measurements were registered and blood samples were taken after an overnight fast.
Results: The mean values of different parameters showed significant differences between both groups. The total testosterone mean value was (338,97±91,2 ng/ml) substantially lower as compared to patients with metabolic syndrome to control group.
Conclusion: There is an inverse relationship between total testosterone and metabolic syndrome. Low total testosterone can be a predictor of rising incidence of metabolic syndrome.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Haller H. Epidermiology and associated risk factors of hyperlipoproteinemia Z Gesamte Inn Med 32(8): 124–28 1977
2. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease". Diabetes 37(12): 1595–607 1988
3. Travison TG Araujo AB O’Donnell AB Kupelian V McKnlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab 92(1): 196-202 2007
4. Lopez DS Canfield S Wang R. Testosterone replacement therapy and the heart: friend foe or bystander? Transl Androl Urol 5(6):898-9082016
5. Lopez DS Advani S Tsilidis KK Wang R Canfield S. Endogenous and exogenous testosterone and prostate cancer: decreased increased or null-risk? Transl Androl Urol. 6(3): 566-579 2017
6. Bjorntorp P. Endocrine abnormalities in obesity. Diabetes Rev 5: 52-68 1997
7. Laaksonen DE Niskanen L Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5):1036-1041 2004
8. Kolovou GD Anagnostopoulou KK Salpea KD Mikhailidis DP. The prevalence of metabolic syndrome in various populations Am J Med Sci 333(6): 362-71 2007
9. Qabulio SN Akhtar S Ziauddin F Khan W Afridi SA. Prevalence of the Metabolic Syndrome in Low Socio-Economic Urban Population. ISRA Medical JournalVolume 10(5): 291-295 2018
10. Alberti KGMM Eckel RH Grundy SM et al. Harmonizing the metabolic syndrome: a joint statement of the international diabetes federation task force on epidemiology and prevention; National heart lung and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity. Circulation 120(16): 1640-1645 2009
11. Laaksonen DE Niskanen L Punnonen K et al. Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care 27(5): 1036-41 2004
12. Kupelian V Page ST Araujo AB et al. Low sex hormone-binding globulin total testosterone and symptomatic androgen deficiency are associated with development of the metabolic syndrome in non-obese men J Clin Endocrinol Metab 91(3): 843-850 2006
13. Kapoor D Malkin CJ Channer KS Jones TH. Androgens insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63(3): 239-50 2005.